<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CPR</journal-id>
<journal-id journal-id-type="hwp">spcpr</journal-id>
<journal-title>European Journal of Preventive Cardiology</journal-title>
<issn pub-type="ppub">2047-4873</issn>
<issn pub-type="epub">2047-4881</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1741826711414624</article-id>
<article-id pub-id-type="publisher-id">10.1177_1741826711414624</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Rehabilitation</subject>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Exercise training and cardiac rehabilitation in patients with implantable cardioverter defibrillators: a review of current literature focusing on safety, effects of exercise training, and the psychological impact of programme participation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Isaksen</surname><given-names>Kjetil</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711414624">1</xref>
<xref ref-type="aff" rid="aff2-1741826711414624">2</xref>
<xref ref-type="corresp" rid="corresp1-1741826711414624"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Morken</surname><given-names>Ingvild Margreta</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711414624">1</xref>
<xref ref-type="aff" rid="aff3-1741826711414624">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Munk</surname><given-names>Peter Scott</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711414624">1</xref>
<xref ref-type="aff" rid="aff2-1741826711414624">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Larsen</surname><given-names>Alf Inge</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711414624">1</xref>
<xref ref-type="aff" rid="aff2-1741826711414624">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-1741826711414624"><label>1</label>Stavanger University Hospital, Norway.</aff>
<aff id="aff2-1741826711414624"><label>2</label>University of Bergen, Norway.</aff>
<aff id="aff3-1741826711414624"><label>3</label>University of Stavanger, Norway.</aff>
<author-notes>
<corresp id="corresp1-1741826711414624">Kjetil Isaksen, Department of Cardiology, Stavanger University Hospital, PO Box 8100, 4068 Stavanger, Norway Email: <email>kjetil.isaksen@lyse.net</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2012</year>
</pub-date>
<volume>19</volume>
<issue>4</issue>
<fpage>804</fpage>
<lpage>812</lpage>
<history>
<date date-type="received"><day>1</day><month>12</month><year>2010</year></date>
<date date-type="accepted"><day>2</day><month>6</month><year>2011</year></date>
</history>
<permissions>
<copyright-statement>© The European Society of Cardiology 2011 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="society">European Society of Cardiology</copyright-holder>
</permissions>
<abstract>
<p><bold>Background:</bold> Indications for implantable cardioverter defibrillators (ICDs) have been widened considerably during the last decade due to the well-documented effect in the heart failure population. Exercise training (ET) has a 1 A recommendation in heart failure. However, data on safety and efficacy of ET in patients with ICDs is sparse. ICD shocks are associated with reduced quality of life and increased mortality. Whether ET may have a beneficial effect in heart failure patients with an ICD is not well documented.</p>
<p><bold>Methods:</bold> This review is based on a systematic search in the Pub Med database using the terms ‘exercise training’, ‘implantable cardioverter defibrillator’, and ‘cardiac rehabilitation’.</p>
<p><bold>Results:</bold> Nine studies were identified, comprising 1889 patients. The average duration of exercise-based cardiac rehabilitation (CR) was 9.6 weeks. Ten ICD therapies (seven shocks) were reported in the 834 patients with ICD during ET. Between exercise sessions and during follow up 182 events were recorded including 166 shocks. Three studies (2 randomized) showed that the control group representing sedentary patients were more prone to ICD discharge than patients undergoing CR/ET. In all studies the ICD patients improved their aerobic fitness following ET. Few studies report data on the effect of ET on anxiety and depression.</p>
<p><bold>Conclusion:</bold> Based on the current literature, ET in patients with an ICD seems to be safe and is not associated with increased risk of shocks. ET improves aerobic capacity in ICD patients, while effects on anxiety, depression and quality of life are still under debate.</p>
</abstract>
<kwd-group>
<kwd>Aerobic exercise</kwd>
<kwd>arrhythmias</kwd>
<kwd>cardiac rehabilitation</kwd>
<kwd>exercise training</kwd>
<kwd>implantable cardioverter defibrillator</kwd>
<kwd>quality of life</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1741826711414624" sec-type="intro"><title>Introduction</title>
<p>Implantable cardioverter defibrillators (ICD) in patients resuscitated from sudden cardiac death is associated with a significant survival benefit.<sup><xref ref-type="bibr" rid="bibr1-1741826711414624">1</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr5-1741826711414624">5</xref></sup> The extension of the indications for this device to patients with symptomatic heart failure and a left ventricular ejection fraction (EF) below 30% has led to an explosive increase in implantation rates in the Western world.<sup><xref ref-type="bibr" rid="bibr6-1741826711414624">6</xref></sup></p>
<p>The beneficial effects of cardiac rehabilitation (CR) and exercise training (ET) on physical and psychosocial functioning in heart failure patients are well established.<sup><xref ref-type="bibr" rid="bibr7-1741826711414624">7</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr11-1741826711414624">11</xref></sup> However, heart failure patients with an ICD often seem reluctant to participate in CR due to the fear of an ET-induced shock.<sup><xref ref-type="bibr" rid="bibr12-1741826711414624">12</xref>,<xref ref-type="bibr" rid="bibr13-1741826711414624">13</xref></sup> Anxiety and depression are more pronounced in the ICD population compared to the population at large, and avoidance of behaviour typically involving increased physical activity are frequently reported.<sup><xref ref-type="bibr" rid="bibr14-1741826711414624">14</xref></sup> On the other hand sparse data exist on whether ET might reduce anxiety and depression.</p>
<p>Neither the European Society of Cardiology (ESC) nor the American Heart Association/American College of Cardiology (AHA/ACC) has prepared separate guidelines on CR/ET for the specified ICD patient. As a consequence of this, physician recommendations to ICD patients regarding participation in ET vary widely.<sup><xref ref-type="bibr" rid="bibr15-1741826711414624">15</xref></sup> However, a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology, and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology suggests sports activity in stable patients at a low static or dynamic intensity.<sup><xref ref-type="bibr" rid="bibr16-1741826711414624">16</xref></sup> Moreover, the study group on Sports cardiology of the European Association for Cardiovascular Prevention and Rehabilitation suggests that the indication for an ICD is no substitute for the guidelines relating to the underlying pathology.<sup><xref ref-type="bibr" rid="bibr17-1741826711414624">17</xref></sup></p>
<p>The aims of this review on exercise training in ICD patients are to assess the following:
<list id="list1-1741826711414624" list-type="order">
<list-item><p>Risk of arrhythmia during exercise: safety and feasibility of ET in ICD patients</p></list-item>
<list-item><p>Aerobic fitness response to ET in the ICD patient population</p></list-item>
<list-item><p>Impact of ET on psychosocial wellbeing/health</p></list-item>
</list></p>
</sec>
<sec id="sec2-1741826711414624" sec-type="methods"><title>Methods</title>
<p>We conducted a systematic literature search using Pub Med by combining the key words ‘exercise training’ and ‘implantable cardioverter defibrillator’ with ‘cardiac rehabilitation’. Publications thought to contain relevant information on the topic were extracted. Both retrospective and prospective studies were included. We also examined the reference list from relevant articles found on Pub Med.</p>
</sec>
<sec id="sec3-1741826711414624" sec-type="results"><title>Results</title>
<p>Nine studies published between 2001 and 2009 were identified to contain relevant information on the topic. Descriptive data on the studies are depicted in <xref ref-type="table" rid="table1-1741826711414624">Table 1</xref>.<sup><xref ref-type="bibr" rid="bibr18-1741826711414624">18</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr26-1741826711414624">26</xref></sup> From this pool of studies seven had a prospective design, while two were retrospective.
<table-wrap id="table1-1741826711414624" position="float"><label>Table 1.</label><caption><p>Demographics and occurrence of implantable cardioverter defibrillator therapies during and between exercise training sessions in the various studies</p></caption>
<graphic alternate-form-of="table1-1741826711414624" xlink:href="10.1177_1741826711414624-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Study</th>
<th>Design</th>
<th>No. of ICD/no. of control (programme duration, weeks)</th>
<th>% Ejection fraction (ICD/control)</th>
<th>ICD indication (primary/ secondary, %)</th>
<th>Ischaemic aetiology (<italic>n</italic>/total, %)</th>
<th colspan="2">ICD therapy during exercise (appropriate/ inappropriate)<hr/></th>
<th colspan="2">ICD therapy between exercise (appropriate/ inappropriate)<hr/></th></tr>
<tr>
<td colspan="6"/>
<td>Shock</td>
<td>ATP</td>
<td>Shock</td>
<td>ATP</td></tr></thead>
<tbody align="left">
<tr>
<td colspan="10">Evaluating ICD patients, no control group</td></tr>
<tr>
<td>Dougherty et al. (2008)<sup><xref ref-type="bibr" rid="bibr23-1741826711414624">23</xref></sup></td>
<td>Prosp NC NR</td>
<td>10/0 (8 weeks)</td>
<td>39.2 ± 19.8</td>
<td>0/10 (0/100%)</td>
<td>4/10 (40%)</td>
<td>0/0</td>
<td>0/0</td>
<td>ND</td>
<td>ND</td></tr>
<tr>
<td>Kamke et al. (2003)<sup><xref ref-type="bibr" rid="bibr22-1741826711414624">22</xref></sup></td>
<td>Prosp NC NR</td>
<td>118/0 (3.5 weeks)</td>
<td>38 ± 12.7</td>
<td>22/96 (81/19%)</td>
<td>82/118 (69.5%)</td>
<td>0/0</td>
<td>0/0</td>
<td>7/1</td>
<td>7/6</td></tr>
<tr>
<td colspan="10">Comparing ICD patients with cardiac non-ICD controls, both groups exercise</td></tr>
<tr>
<td>Vanhees et al. (2001)<sup><xref ref-type="bibr" rid="bibr19-1741826711414624">19</xref></sup></td>
<td>Prosp CO NR</td>
<td>8/16 (12 weeks)</td>
<td>44 ± 10/43 ± 6</td>
<td>ND</td>
<td>ND</td>
<td>1/0</td>
<td>1/0</td>
<td>0/0</td>
<td>0/0</td></tr>
<tr>
<td>Vanhees et al. (2004)<sup><xref ref-type="bibr" rid="bibr21-1741826711414624">21</xref></sup></td>
<td>Prosp CO NR</td>
<td>92/473 (12 weeks)</td>
<td>&lt;40 (68/13)</td>
<td>ND</td>
<td>414/565 (73.3%)</td>
<td>3/1</td>
<td>2/0</td>
<td>6/0</td>
<td>0/0</td></tr>
<tr>
<td>Fan et al. (2009)<sup><xref ref-type="bibr" rid="bibr24-1741826711414624">24</xref></sup></td>
<td>Retro CO NR</td>
<td>42/42 (ND)</td>
<td>32 ± 15/36 ± 13</td>
<td>7/34 (18/78%)</td>
<td>ND</td>
<td>0/1</td>
<td>0/0</td>
<td>0/0</td>
<td>0/0</td></tr>
<tr>
<td colspan="10">Comparing ICD patients with ICD controls, crossover design</td></tr>
<tr>
<td>Fitchet et al. (2003)<sup><xref ref-type="bibr" rid="bibr18-1741826711414624">18</xref></sup></td>
<td>Prosp CO RA</td>
<td>8/8 (12 weeks)</td>
<td>38 ± 17</td>
<td>ND</td>
<td>11/16 (68.8%)</td>
<td>0/0</td>
<td>0/0</td>
<td>2<sup><xref ref-type="table-fn" rid="table-fn2-1741826711414624">a</xref></sup></td>
<td>3/0</td></tr>
<tr>
<td colspan="10">ICD patients with sedentary ICD control patients</td></tr>
<tr>
<td>Davids et al. (2005)<sup><xref ref-type="bibr" rid="bibr25-1741826711414624">25</xref></sup></td>
<td>Retro CO NR</td>
<td>28/54 (ND)</td>
<td>37 ± 2/35 ± 2</td>
<td>37/45 (45.1/54.9%)</td>
<td>82/82 (100%)</td>
<td>0/0<sup><xref ref-type="table-fn" rid="table-fn3-1741826711414624">b</xref></sup> ND</td>
<td>7/4<sup><xref ref-type="table-fn" rid="table-fn4-1741826711414624">c</xref></sup> ND</td>
<td>4/5<sup><xref ref-type="table-fn" rid="table-fn3-1741826711414624">b</xref></sup> ND</td>
<td>21/17<sup><xref ref-type="table-fn" rid="table-fn4-1741826711414624">c</xref></sup> ND</td></tr>
<tr>
<td>Belardinelli et al. (2006)<sup><xref ref-type="bibr" rid="bibr20-1741826711414624">20</xref></sup></td>
<td>Prosp CO RA</td>
<td>30/22 (8 weeks)</td>
<td>31 ± 7</td>
<td>33/19 (63.5/36.5%)</td>
<td>52/52 (100%)</td>
<td>0/0</td>
<td>0/0</td>
<td>0/0</td>
<td>0/0 (8/0)<sup><xref ref-type="table-fn" rid="table-fn5-1741826711414624">d</xref></sup></td></tr>
<tr>
<td>O’Connor et al. (2009)<sup><xref ref-type="bibr" rid="bibr26-1741826711414624">26</xref></sup></td>
<td>Prosp CO RA</td>
<td>490/448 (12 weeks)<sup><xref ref-type="table-fn" rid="table-fn6-1741826711414624">e</xref></sup></td>
<td>24.9/24.6</td>
<td>ND</td>
<td>1197/2331 (51%)</td>
<td>1<sup><xref ref-type="table-fn" rid="table-fn2-1741826711414624">a</xref></sup></td>
<td>ND</td>
<td>141<sup><xref ref-type="table-fn" rid="table-fn2-1741826711414624">a</xref></sup></td>
<td>151<sup><xref ref-type="table-fn" rid="table-fn5-1741826711414624">d</xref></sup></td></tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1741826711414624"><p>ATP, antitachycardia pacing; CO, controlled; ejection fraction;ICD, implantable cardioverter defibrillator; NC, not controlled; ND, no data; NR, not randomized; Prosp, prospective; RA, randomized; Retro, retrospective.</p></fn>
<fn id="table-fn2-1741826711414624"><label>a</label><p>Not specified whether appropriate or not.</p></fn>
<fn id="table-fn3-1741826711414624"><label>b</label><p>ICD shocks recorded in group after completed cardiac rehabilitation.</p></fn>
<fn id="table-fn4-1741826711414624"><label>c</label><p>ICD shocks recorded in group not participating in cardiac rehabilitation.</p></fn>
<fn id="table-fn5-1741826711414624"><label>d</label><p>Shocks received by sedentary control patients during study and follow up.</p></fn>
<fn id="table-fn6-1741826711414624"><label>e</label><p>Numbers of patients in exercise training group/sedentary controls, both groups with an ICD in the HF-ACTION trial.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>The number of patients in each study ranged from ten to 938. In total 1889 patients were included, while 834 ICD patients have participated in ET in the various trials. Three studies are prospective, randomized and controlled with ICD patients in both exercise and sedentary arms. The duration of organized cardiac rehabilitation varied between 4 and 12 weeks. Four studies report data only from the cardiac rehabilitation period,<sup><xref ref-type="bibr" rid="bibr19-1741826711414624">19</xref>,<xref ref-type="bibr" rid="bibr21-1741826711414624">21</xref>,<xref ref-type="bibr" rid="bibr22-1741826711414624">22</xref>,<xref ref-type="bibr" rid="bibr24-1741826711414624">24</xref></sup> while the remaining five also report data from follow-up periods ranging from 12 weeks to 48 months.<sup><xref ref-type="bibr" rid="bibr18-1741826711414624">18</xref>,<xref ref-type="bibr" rid="bibr20-1741826711414624">20</xref>,<xref ref-type="bibr" rid="bibr23-1741826711414624">23</xref>,<xref ref-type="bibr" rid="bibr25-1741826711414624">25</xref>,<xref ref-type="bibr" rid="bibr26-1741826711414624">26</xref></sup> As shown in <xref ref-type="table" rid="table1-1741826711414624">Table 1</xref>, ischaemic heart disease was the underlying condition in the majority of patients. The degree of left ventricular function in the various studies varied between an EF of 25–44%, the former referring to the HF-ACTION trial. A major limitation of the literature data is that they are mostly referring to secondary prevention patients, whereas the increase in ICD implantations is based on primary prophylaxis.</p>
<p>Due to the heterogeneity of the studies the patient populations cannot be pooled in order to perform a meta-analysis.</p>
<sec id="sec4-1741826711414624"><title>Risk of arrhythmia during exercise: safety and feasibility of exercise training in ICD patients</title>
<p>During exercise, ten ICD therapies have been described in the population of 834 ICD patients (<xref ref-type="table" rid="table1-1741826711414624">Table 1</xref>). Seven of the ten events were shocks, two of which were inappropriate. Six of the ten ICD therapies occurred in the same study,<sup><xref ref-type="bibr" rid="bibr21-1741826711414624">21</xref></sup> leaving four events (three appropriate and one inappropriate) in the remaining eight studies comprising 742 ICD patients.</p>
<p>Between exercise sessions, 182 events were recorded.</p>
<p>For the studies with sedentary ICD controls (<xref ref-type="table" rid="table1-1741826711414624">Table 1</xref>), ICD discharges were more frequent in the sedentary control group than in the ET group. The multicentre randomized controlled HF-ACTION trial examining the effects of exercise training in 2331 heart failure patients contained 938 patients with an ICD. Regarding safety, one exercise session was terminated due to an ICD discharge in this large study. Further, the total number of ICD discharges throughout the study was somewhat lower in the exercise group compared with the sedentary control group. In the randomized study by Belardinelli et al.<sup><xref ref-type="bibr" rid="bibr20-1741826711414624">20</xref></sup> the sedentary ICD control group comprising 22 patients had eight ICD shocks leading to hospitalizations compared to none in the 30 ET patients during the study period and 18-month follow up.</p>
</sec>
<sec id="sec5-1741826711414624"><title>Aerobic fitness response to exercise training in the ICD patient population</title>
<p>All studies used different types of aerobic exercise, including ergometer cycling and walking or running on a treadmill. Intensity levels ranged from 60 to 80% of maximal heart rate or heart rate reserve. The evaluation of the ET effect on cardiovascular capacity/fitness varied between the different studies.</p>
<p>Pre- and post-interventional maximal oxygen uptake (VO<sub>2max</sub>) testing was performed in five of nine studies. The two studies by Vanhees et al.<sup><xref ref-type="bibr" rid="bibr19-1741826711414624">19</xref>,<xref ref-type="bibr" rid="bibr21-1741826711414624">21</xref></sup> comprising 100 ICD patients and 489 non-ICD cardiac controls compared the effectiveness of ET in ICD versus non-ICD patients. Both ICD and control groups achieved significant improvements in VO<sub>2max</sub> with a more pronounced effect in the non-ICD group. It is important to note that in the HF-ACTION trial ET lead to a 4% increase in peak oxygen consumption and hence failed to reach the 10% targeted improvement specified in the study protocol. In numbers, VO<sub>2max</sub> increased from baseline 14.4 to 15 ml/kg/min after 3 months in the intervention group. Belardinelli et al.<sup><xref ref-type="bibr" rid="bibr20-1741826711414624">20</xref></sup> documented a significant improvement in VO<sub>2max</sub> following ET in ICD patients compared with no changes in ICD control patients. The remaining prospective studies used the change in ergometric load and the treadmill test time during the ET programme as measures for improvements in aerobic fitness, all reporting significant improvements.</p>
</sec>
<sec id="sec6-1741826711414624"><title>Impact of exercise training on psychosocial wellbeing/health</title>
<p>Three studies including 78 ICD patients reported data on psychosocial functioning after ET (<xref ref-type="table" rid="table2-1741826711414624">Table 2</xref>). In the study by Fitchet et al.<sup><xref ref-type="bibr" rid="bibr18-1741826711414624">18</xref></sup> patients were supervised by a health psychologist in addition to the ET programme. Although this study included only 16 patients, significant reductions in depression and anxiety immediately after and at follow up 12 weeks post ET were reported. Belardinelli et al.<sup><xref ref-type="bibr" rid="bibr20-1741826711414624">20</xref></sup> also referred to significant improvements in psychological wellbeing. These improvements were seen in the subsegment of cardiac resynchronization therapy patients, evaluated with the Minnesota Living with Heart Failure questionnaire. No significant improvement of psychological wellbeing was found in the ICD group.
<table-wrap id="table2-1741826711414624" position="float"><label>Table 2.</label><caption><p>Psychological effects of exercise training/cardiac rehabilitation on implantable cardioverter defibrillator patients in cardiac rehabilitation programme</p></caption>
<graphic alternate-form-of="table2-1741826711414624" xlink:href="10.1177_1741826711414624-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Study</th>
<th>Health education and psychological intervention</th>
<th>Objective measures of psychosocial functioning following participation</th></tr></thead>
<tbody align="left">
<tr>
<td align="justify">Fitchet et al. (2003)<sup><xref ref-type="bibr" rid="bibr18-1741826711414624">18</xref></sup></td>
<td align="justify">Information on benefits of exercise, cardiovascular disease, ICD technical information, advice on diets</td>
<td align="justify">HADS score for anxiety: BL 13.4 (SD 3.6), post CR 8.1 (SD 3.6)<sup><xref ref-type="table-fn" rid="table-fn8-1741826711414624">a</xref></sup></td></tr>
<tr>
<td/>
<td align="justify">Use of a health psychologist with sessions on anxiety and depression management, self-help strategies. Some pts offered individual counselling</td>
<td align="justify">HADS score for depression: BL 9.9 (SD 3.4), post CR 6.7 (SD 2.9)<sup><xref ref-type="table-fn" rid="table-fn8-1741826711414624">a</xref></sup></td></tr>
<tr>
<td colspan="2"/>
<td align="justify">Improvements maintained 12 weeks after CR</td></tr>
<tr>
<td align="justify">Belardinelli et al. (2006)<sup><xref ref-type="bibr" rid="bibr20-1741826711414624">20</xref></sup></td>
<td align="justify">Exercise training only, no separate health education or psychosocial interventions</td>
<td align="justify">Minnesota Living with Heart Failure Questionnaire: QOL sum score: sign improvement only in ICD-CRT group: BL 54 ± 18, PE 40 ± 20<sup><xref ref-type="table-fn" rid="table-fn9-1741826711414624">b</xref>,<xref ref-type="table-fn" rid="table-fn10-1741826711414624">c</xref></sup></td></tr>
<tr>
<td colspan="2"/>
<td align="justify">Non significant improvement in ICD group</td></tr>
<tr>
<td align="justify">Dougherty et al. (2008)<sup><xref ref-type="bibr" rid="bibr23-1741826711414624">23</xref></sup></td>
<td align="justify">Exercise training only, no separate health education or psychosocial interventions</td>
<td align="justify">SF-12 mental composite summary: improvement reported at 8 weeks, slight decline at 6 months<sup><xref ref-type="table-fn" rid="table-fn11-1741826711414624">d</xref></sup></td></tr>
<tr>
<td colspan="2"/>
<td align="justify">STAI: reduced at 8 weeks, slightly increased at 6 months<sup><xref ref-type="table-fn" rid="table-fn11-1741826711414624">d</xref></sup></td></tr>
<tr>
<td colspan="2"/>
<td align="justify">CES-D: reduced at 8 weeks, slightly increased at 6 months<sup><xref ref-type="table-fn" rid="table-fn11-1741826711414624">d</xref></sup></td></tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn7-1741826711414624"><p>BL, baseline; CES-D, Centre for Epidemiologic Studies depression scale; CR, cardiac rehabilitation; CRT, cardiac resynchronization therapy; HADS, Hospital Anxiety and Depression Scale; ICD, implantable cardioverter defibrillator; QOL, quality of life; SD, standard deviation; SF-12, Short Form-12; STAI, state-trait anxiety inventory.</p></fn>
<fn id="table-fn8-1741826711414624"><label>a</label><p><italic>p</italic>&lt;0.001.</p></fn>
<fn id="table-fn9-1741826711414624"><label>b</label><p><italic>p</italic>&lt;0.001 vs. control group.</p></fn>
<fn id="table-fn10-1741826711414624"><label>c</label><p><italic>p</italic>&lt;0.05 vs. ICD group.</p></fn>
<fn id="table-fn11-1741826711414624"><label>d</label><p>Non-significant changes.</p></fn></table-wrap-foot>
</table-wrap></p>
</sec>
</sec>
<sec id="sec7-1741826711414624" sec-type="discussion"><title>Discussion</title>
<p>The studies included in this review reported seven shocks during exercise training in 834 ICD patients. The shocks were recorded over an average training period of 9.6 weeks. Patients participating in exercise training in two randomized controlled studies had a reduced frequency of shocks between the ET sessions compared with sedentary controls. Although ET is well established in the rehabilitation of patients with heart disease including patients with heart failure, only sparse data exist with regard to the safety and exercise effects in patients with an ICD. Most studies reported are not randomized and have a heterogeneous design. However, all nine studies included in this review consistently indicate that ET is beneficial also in ICD patients. Further, patients who have received an ICD based on the MADIT II criteria, have a 1A indication for ET. Hence, we should assure that these patients can profit from the benefits of ET.</p>
<p>Unfortunately, the randomized multicentre RELAX-ICD trial was recently terminated due to recruitment problems. This trial with three arms was designed to compare the effects of ET to exercise in combination with cognitive behavioural therapy (CBT) with a third arm serving as a control group without intervention. Recruitment of the ICD patients to exercise training was not the problematic issue; however, execution of the CBT part of the study was difficult. This highlights an important and problematic issue, namely the vast resources needed over multiple specialties (cardiologists, physiotherapists, psychologists) to carry out such complex trials.</p>
<sec id="sec8-1741826711414624"><title>Risk of arrhythmia during exercise: safety and feasibility of exercise training in ICD patients</title>
<p>All patients with an ICD should be evaluated with an exercise stress test before entering an ET programme to assess potential inducible ischaemia and arrhythmia. Further, the maximal achievable heart rate in response to an incremental stress test should be considerably below the programmed ICD threshold for therapy to minimize the risk for inappropriate shocks.</p>
<p>The incidence of cardiovascular events during organized ET programmes in the population with coronary heart disease is very low with one estimated major cardiovascular complication per 100,000 patient hours and one fatality per 750,000 patient-hours.<sup><xref ref-type="bibr" rid="bibr27-1741826711414624">27</xref></sup> The ICD population however constitutes a subset of patients with an increased risk for arrhythmic complications. Following an initial evaluation including a stress test, ICD patients may enrol in an ET programme under the supervision of experienced staff with necessary skills in cardiopulmonary resuscitation. Following these steps most ICD patients will do fine without any specific surveillance in the ET setting, leaving special attention for high-risk ICD patients.</p>
<p>We should aim towards giving ICD patients the opportunity to conduct an active lifestyle spanning from the daily physical activities of life to ET. Thus, they should be encouraged to continue organized and unorganized activity after a run-in period in a rehabilitation centre. Based on the findings from the few ICD training studies and on the data from the heart failure training trials, this might even decrease costs related to the continuing rehabilitation of this patient population. The HF-ACTION study<sup><xref ref-type="bibr" rid="bibr26-1741826711414624">26</xref></sup> has already proved the safety and benefit of ET in the heart failure population. In this study 45% of the 2331 patients included had an ICD. Only one patient had an ICD discharge during exercise in the intervention group leading to a premature end of the training session.</p>
<p>In the current reports no fatalities occurred during ET and no pre-exercise programme tests were terminated due to pulse rates close to ICD threshold, probably due to the heart rate lowering effect of beta-blockers in this population.</p>
</sec>
<sec id="sec9-1741826711414624"><title>Aerobic fitness response to exercise training in the ICD patient population</title>
<p>All cited studies reported an exercise induced increase in aerobic capacity in the ICD group. However, Vanhees et al.<sup><xref ref-type="bibr" rid="bibr21-1741826711414624">21</xref></sup> found smaller but significant improvements in VO<sub>2max</sub> in the ICD population compared with non-ICD cardiac controls following CR. It is also worth noting that Belardinelli et al.<sup><xref ref-type="bibr" rid="bibr20-1741826711414624">20</xref></sup> found greater improvements in aerobic fitness in the cardiac resynchronization therapy group compared with ICD only.</p>
<p>As the effect of ET on aerobic capacity in heart failure is dependent on exercise intensity, this difference could be a consequence of ICD patients being afraid of training at high intensity levels. The use of beta-blockers does not prevent the effect of ET on VO<sub>2max</sub> in patients with heart failure, as shown by Wisløff et al.<sup><xref ref-type="bibr" rid="bibr28-1741826711414624">28</xref></sup></p>
<sec id="sec10-1741826711414624"><title>Mechanisms</title>
<p>In patients with ischaemic heart disease (IHD), prolonged and repeated training sessions inducing myocardial ischaemia lasting up to 60 min are well tolerated without evidence of myocardial injury, significant arrhythmias or left ventricular dysfunction.<sup><xref ref-type="bibr" rid="bibr29-1741826711414624">29</xref></sup> On the other hand, there are also reports that ET in the ischaemic heart may elicit potentially fatal arrhythmias, as observed during stress ECG testing prior to revascularization.<sup><xref ref-type="bibr" rid="bibr30-1741826711414624">30</xref>,<xref ref-type="bibr" rid="bibr31-1741826711414624">31</xref></sup></p>
<p>Although most patients are revascularized before entering an ET programme, ischaemia may be apparent in parts of the myocardium during training at high intensity in patients with coronary artery disease. A successive increase in intensity during the programme may thus induce beneficial effects like collateral formation and improved endothelial function, which reduce ischaemia during bouts of exercise.</p>
</sec>
</sec>
<sec id="sec11-1741826711414624"><title>Impact of exercise training on psychosocial aspects like anxiety and depression</title>
<p>Anxiety and fear are the dominant psychological manifestations experienced by ICD recipients.<sup><xref ref-type="bibr" rid="bibr32-1741826711414624">32</xref></sup> In addition depressive symptoms in this population are common and associated with increased mortality.<sup><xref ref-type="bibr" rid="bibr33-1741826711414624">33</xref></sup> The strongest predictor for this psychopathological response has been shown to be the frequency of shocks experienced.<sup><xref ref-type="bibr" rid="bibr34-1741826711414624">34</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr36-1741826711414624">36</xref></sup> However, the underlying mechanisms are complex and multifactorial.<sup><xref ref-type="bibr" rid="bibr37-1741826711414624">37</xref></sup> The type D personality, characterized by high negative effect and high social inhibition, has been linked to the development of chronic anxiety in this population.<sup><xref ref-type="bibr" rid="bibr38-1741826711414624">38</xref></sup> Female gender and younger age also seem to predispose for anxiety and ICD concerns.<sup><xref ref-type="bibr" rid="bibr39-1741826711414624">39</xref></sup> Factors like the perception of control of shocks, as well as the predictability of shocks and psychological attributions made by the patient regarding the device also has to be considered.</p>
<p>Several studies have described ICD recipients’ fear of shock due to overexertion (high pulse rates), which subsequently may lead to a persistently reduced physical activity levels.<sup><xref ref-type="bibr" rid="bibr40-1741826711414624">40</xref>,<xref ref-type="bibr" rid="bibr41-1741826711414624">41</xref></sup> This fear of exercise is also negatively associated with health-related quality of life.<sup><xref ref-type="bibr" rid="bibr13-1741826711414624">13</xref></sup> In the current review we found a positive effect both on quality of life measured with the Minnesota Living with Heart Failure questionnaire and reduced symptoms of depression and anxiety (<xref ref-type="table" rid="table2-1741826711414624">Table 2</xref>). However, only three studies with a total of 78 ICD patients constitute a weak foundation. As depicted in <xref ref-type="table" rid="table2-1741826711414624">Table 2</xref>, no uniform conclusions can be made on the existing knowledge base regarding these issues.</p>
</sec>
</sec>
<sec id="sec12-1741826711414624" sec-type="conclusions"><title>Conclusions</title>
<p>In this review we found that ET in ICD patients seems to be safe. Due to lack of significant scientific evidence it is not possible to conclude on whether ET may be associated with a reduced risk for arrhythmias and/or ICD shocks. However, ET improves functional capacity and may also improve quality of life.</p>
<p>Several programmes are now running to study the ET effects in patients with an ICD. We are currently performing a controlled trial to evaluate mechanisms and psychological aspects in ICD patients related to training (ClinicalTrials.gov identifier NCT01038960). However, large randomized controlled trials are needed to document the beneficial effects of ET in the increasing population of ICD patients, not only with regard to morbidity, but also with regard to anxiety, depression and quality of life.</p>
<p>Guidelines for ET in patients with an ICD are no substitute for the guidelines relating to the underlying pathology. Based on the existing data we have constructed a simplified flow scheme for the pre- exercise evaluation and execution of ET in patients with ischaemic cardiomyopaty and an ICD (<xref ref-type="fig" rid="fig1-1741826711414624">Figure 1</xref>).
<fig id="fig1-1741826711414624" position="float"><label>Figure 1.</label><caption><p>Flow scheme for assessment of patients with ischaemic cardiomyopathy and ICD with regard to exercise training.</p></caption><graphic xlink:href="10.1177_1741826711414624-fig1.tif"/></fig></p>
</sec>
</body>
<back>
<sec id="sec13-1741826711414624"><title>Funding</title>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</sec>
<sec id="sec14-1741826711414624"><title>Conflicts of interest</title>
<p>None.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="bibr1-1741826711414624"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>AJ</given-names></name><name><surname>Hall</surname><given-names>WJ</given-names></name><name><surname>Cannom</surname><given-names>DS</given-names></name><name><surname>Daubert</surname><given-names>JP</given-names></name><name><surname>Higgins</surname><given-names>SL</given-names></name><name><surname>Klein</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators</article-title>. <source>N Engl J Med</source> <year>1996</year>; <volume>335</volume>(<issue>26</issue>): <fpage>1933</fpage>–<lpage>1940</lpage>.</citation></ref>
<ref id="bibr2-1741826711414624"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bardy</surname><given-names>GH</given-names></name><name><surname>Lee</surname><given-names>KL</given-names></name><name><surname>Mark</surname><given-names>DB</given-names></name><name><surname>Poole</surname><given-names>JE</given-names></name><name><surname>Packer</surname><given-names>DL</given-names></name><name><surname>Boineau</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure</article-title>. <source>N Engl J Med</source> <year>2005</year>; <volume>352</volume>(<issue>3</issue>): <fpage>225</fpage>–<lpage>237</lpage>.</citation></ref>
<ref id="bibr3-1741826711414624"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias</surname><given-names>A</given-names></name></person-group>. <article-title>The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators</article-title>. <source>N Engl J Med</source> <year>1997</year>; <volume>337</volume>(<issue>22</issue>): <fpage>1576</fpage>–<lpage>1583</lpage>.</citation></ref>
<ref id="bibr4-1741826711414624"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siebels</surname><given-names>J</given-names></name><name><surname>Kuck</surname><given-names>KH</given-names></name></person-group>. <article-title>Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg)</article-title>. <source>Am Heart J</source> <year>1994</year>; <volume>127</volume>(<issue>4</issue>): <fpage>1139</fpage>–<lpage>1144</lpage>.</citation></ref>
<ref id="bibr5-1741826711414624"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buxton</surname><given-names>AE</given-names></name><name><surname>Lee</surname><given-names>KL</given-names></name><name><surname>Fisher</surname><given-names>JD</given-names></name><name><surname>Josephson</surname><given-names>ME</given-names></name><name><surname>Prystowsky</surname><given-names>EN</given-names></name><name><surname>Hafley</surname><given-names>G</given-names></name></person-group>. <article-title>A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators</article-title>. <source>N Engl J Med</source> <year>1999</year>; <volume>341</volume>(<issue>25</issue>): <fpage>1882</fpage>–<lpage>1890</lpage>.</citation></ref>
<ref id="bibr6-1741826711414624"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldenberg</surname><given-names>I</given-names></name><name><surname>Moss</surname><given-names>AJ</given-names></name><name><surname>McNitt</surname><given-names>S</given-names></name><name><surname>Zareba</surname><given-names>W</given-names></name><name><surname>Andrews</surname><given-names>ML</given-names></name><name><surname>Hall</surname><given-names>WJ</given-names></name><etal/></person-group>. <article-title>Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction</article-title>. <source>Am J Cardiol</source> <year>2006</year>; <volume>98</volume>(<issue>4</issue>): <fpage>485</fpage>–<lpage>490</lpage>.</citation></ref>
<ref id="bibr7-1741826711414624"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>MJ</given-names></name><name><surname>Higginbotham</surname><given-names>MB</given-names></name><name><surname>Cobb</surname><given-names>FR</given-names></name></person-group>. <article-title>Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects</article-title>. <source>Circulation</source> <year>1988</year>; <volume>78</volume>(<issue>3</issue>): <fpage>506</fpage>–<lpage>515</lpage>.</citation></ref>
<ref id="bibr8-1741826711414624"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coats</surname><given-names>AJ</given-names></name><name><surname>Adamopoulos</surname><given-names>S</given-names></name><name><surname>Radaelli</surname><given-names>A</given-names></name><name><surname>McCance</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>TE</given-names></name><name><surname>Bernardi</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function</article-title>. <source>Circulation</source> <year>1992</year>; <volume>85</volume>(<issue>6</issue>): <fpage>2119</fpage>–<lpage>2131</lpage>.</citation></ref>
<ref id="bibr9-1741826711414624"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adamopoulos</surname><given-names>S</given-names></name><name><surname>Coats</surname><given-names>AJ</given-names></name><name><surname>Brunotte</surname><given-names>F</given-names></name><name><surname>Arnolda</surname><given-names>L</given-names></name><name><surname>Meyer</surname><given-names>T</given-names></name><name><surname>Thompson</surname><given-names>CH</given-names></name><etal/></person-group>. <article-title>Physical training improves skeletal muscle metabolism in patients with chronic heart failure</article-title>. <source>J Am Coll Cardiol</source> <year>1993</year>; <volume>21</volume>(<issue>5</issue>): <fpage>1101</fpage>–<lpage>1106</lpage>.</citation></ref>
<ref id="bibr10-1741826711414624"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Belardinelli</surname><given-names>R</given-names></name><name><surname>Georgiou</surname><given-names>D</given-names></name><name><surname>Scocco</surname><given-names>V</given-names></name><name><surname>Barstow</surname><given-names>TJ</given-names></name><name><surname>Purcaro</surname><given-names>A</given-names></name></person-group>. <article-title>Low intensity exercise training in patients with chronic heart failure</article-title>. <source>J Am Coll Cardiol</source> <year>1995</year>; <volume>26</volume>(<issue>4</issue>): <fpage>975</fpage>–<lpage>982</lpage>.</citation></ref>
<ref id="bibr11-1741826711414624"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>JR</given-names></name><name><surname>Groves</surname><given-names>J</given-names></name><name><surname>Rayos</surname><given-names>G</given-names></name></person-group>. <article-title>Circulatory status and response to cardiac rehabilitation in patients with heart failure</article-title>. <source>Circulation</source> <year>1996</year>; <volume>94</volume>(<issue>7</issue>): <fpage>1567</fpage>–<lpage>1572</lpage>.</citation></ref>
<ref id="bibr12-1741826711414624"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sears</surname><given-names>SF</given-names></name><name><surname>Todaro</surname><given-names>JF</given-names></name><name><surname>Urizar</surname><given-names>G</given-names></name><name><surname>Lewis</surname><given-names>TS</given-names></name><name><surname>Sirois</surname><given-names>B</given-names></name><name><surname>Wallace</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers</article-title>. <source>Pacing Clin Electrophysiol</source> <year>2000</year>; <volume>23</volume>(<issue>6</issue>): <fpage>939</fpage>–<lpage>945</lpage>.</citation></ref>
<ref id="bibr13-1741826711414624"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Ittersum</surname><given-names>M</given-names></name><name><surname>de Greef</surname><given-names>M</given-names></name><name><surname>van Gelder</surname><given-names>I</given-names></name><name><surname>Coster</surname><given-names>J</given-names></name><name><surname>Brugemann</surname><given-names>J</given-names></name><name><surname>van der Schans</surname><given-names>C</given-names></name></person-group>. <article-title>Fear of exercise and health-related quality of life in patients with an implantable cardioverter defibrillator</article-title>. <source>Int J Rehabil Res</source> <year>2003</year>; <volume>26</volume>(<issue>2</issue>): <fpage>117</fpage>–<lpage>122</lpage>.</citation></ref>
<ref id="bibr14-1741826711414624"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lemon</surname><given-names>J</given-names></name><name><surname>Edelman</surname><given-names>S</given-names></name><name><surname>Kirkness</surname><given-names>A</given-names></name></person-group>. <article-title>Avoidance behaviors in patients with implantable cardioverter defibrillators</article-title>. <source>Heart Lung</source> <year>2004</year>; <volume>33</volume>(<issue>3</issue>): <fpage>176</fpage>–<lpage>182</lpage>.</citation></ref>
<ref id="bibr15-1741826711414624"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lampert</surname><given-names>R</given-names></name><name><surname>Cannom</surname><given-names>D</given-names></name><name><surname>Olshansky</surname><given-names>B</given-names></name></person-group>. <article-title>Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society members</article-title>. <source>J Cardiovasc Electrophysiol</source> <year>2006</year>; <volume>17</volume>(<issue>1</issue>): <fpage>11</fpage>–<lpage>15</lpage>.</citation></ref>
<ref id="bibr16-1741826711414624"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pelliccia</surname><given-names>A</given-names></name><name><surname>Fagard</surname><given-names>R</given-names></name><name><surname>Bjornstad</surname><given-names>HH</given-names></name><name><surname>Anastassakis</surname><given-names>A</given-names></name><name><surname>Arbustini</surname><given-names>E</given-names></name><name><surname>Assanelli</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology</article-title>. <source>Eur Heart J</source> <year>2005</year>; <volume>26</volume>(<issue>14</issue>): <fpage>1422</fpage>–<lpage>1445</lpage>.</citation></ref>
<ref id="bibr17-1741826711414624"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heidbuchel</surname><given-names>H</given-names></name><name><surname>Panhuyzen-Goedkoop</surname><given-names>N</given-names></name><name><surname>Corrado</surname><given-names>D</given-names></name><name><surname>Hoffmann</surname><given-names>E</given-names></name><name><surname>Biffi</surname><given-names>A</given-names></name><name><surname>Delise</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers</article-title>. <source>Eur J Cardiovasc Prev Rehabil</source> <year>2006</year>; <volume>13</volume>(<issue>5</issue>): <fpage>475</fpage>–<lpage>484</lpage>.</citation></ref>
<ref id="bibr18-1741826711414624"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fitchet</surname><given-names>A</given-names></name><name><surname>Doherty</surname><given-names>PJ</given-names></name><name><surname>Bundy</surname><given-names>C</given-names></name><name><surname>Bell</surname><given-names>W</given-names></name><name><surname>Fitzpatrick</surname><given-names>AP</given-names></name><name><surname>Garratt</surname><given-names>CJ</given-names></name></person-group>. <article-title>Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial</article-title>. <source>Heart</source> <year>2003</year>; <volume>89</volume>(<issue>2</issue>): <fpage>155</fpage>–<lpage>160</lpage>.</citation></ref>
<ref id="bibr19-1741826711414624"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vanhees</surname><given-names>L</given-names></name><name><surname>Schepers</surname><given-names>D</given-names></name><name><surname>Heidbuchel</surname><given-names>H</given-names></name><name><surname>Defoor</surname><given-names>J</given-names></name><name><surname>Fagard</surname><given-names>R</given-names></name></person-group>. <article-title>Exercise performance and training in patients with implantable cardioverter-defibrillators and coronary heart disease</article-title>. <source>Am J Cardiol</source> <year>2001</year>; <volume>87</volume>(<issue>6</issue>): <fpage>712</fpage>–<lpage>715</lpage>.</citation></ref>
<ref id="bibr20-1741826711414624"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Belardinelli</surname><given-names>R</given-names></name><name><surname>Capestro</surname><given-names>F</given-names></name><name><surname>Misiani</surname><given-names>A</given-names></name><name><surname>Scipione</surname><given-names>P</given-names></name><name><surname>Georgiou</surname><given-names>D</given-names></name></person-group>. <article-title>Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy</article-title>. <source>Eur J Cardiovasc Prev Rehabil</source> <year>2006</year>; <volume>13</volume>(<issue>5</issue>): <fpage>818</fpage>–<lpage>825</lpage>.</citation></ref>
<ref id="bibr21-1741826711414624"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vanhees</surname><given-names>L</given-names></name><name><surname>Kornaat</surname><given-names>M</given-names></name><name><surname>Defoor</surname><given-names>J</given-names></name><name><surname>Aufdemkampe</surname><given-names>G</given-names></name><name><surname>Schepers</surname><given-names>D</given-names></name><name><surname>Stevens</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Effect of exercise training in patients with an implantable cardioverter defibrillator</article-title>. <source>Eur Heart J</source> <year>2004</year>; <volume>25</volume>(<issue>13</issue>): <fpage>1120</fpage>–<lpage>1126</lpage>.</citation></ref>
<ref id="bibr22-1741826711414624"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamke</surname><given-names>W</given-names></name><name><surname>Dovifat</surname><given-names>C</given-names></name><name><surname>Schranz</surname><given-names>M</given-names></name><name><surname>Behrens</surname><given-names>S</given-names></name><name><surname>Moesenthin</surname><given-names>J</given-names></name><name><surname>Voller</surname><given-names>H</given-names></name></person-group>. <article-title>Cardiac rehabilitation in patients with implantable defibrillators. Feasibility and complications</article-title>. <source>Z Kardiol</source> <year>2003</year>; <volume>92</volume>(<issue>10</issue>): <fpage>869</fpage>–<lpage>875</lpage>.</citation></ref>
<ref id="bibr23-1741826711414624"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dougherty</surname><given-names>CM</given-names></name><name><surname>Glenny</surname><given-names>R</given-names></name><name><surname>Kudenchuk</surname><given-names>PJ</given-names></name></person-group>. <article-title>Aerobic exercise improves fitness and heart rate variability after an implantable cardioverter defibrillator</article-title>. <source>J Cardiopulm Rehabil Prev</source> <year>2008</year>; <volume>28</volume>(<issue>5</issue>): <fpage>307</fpage>–<lpage>311</lpage>.</citation></ref>
<ref id="bibr24-1741826711414624"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>S</given-names></name><name><surname>Lyon</surname><given-names>CE</given-names></name><name><surname>Savage</surname><given-names>PD</given-names></name><name><surname>Ozonoff</surname><given-names>A</given-names></name><name><surname>Ades</surname><given-names>PA</given-names></name><name><surname>Balady</surname><given-names>GJ</given-names></name></person-group>. <article-title>Outcomes and adverse events among patients with implantable cardiac defibrillators in cardiac rehabilitation: a case-controlled study</article-title>. <source>J Cardiopulm Rehabil Prev</source> <year>2009</year>; <volume>29</volume>(<issue>1</issue>): <fpage>40</fpage>–<lpage>43</lpage>.</citation></ref>
<ref id="bibr25-1741826711414624"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davids</surname><given-names>JS</given-names></name><name><surname>McPherson</surname><given-names>CA</given-names></name><name><surname>Earley</surname><given-names>C</given-names></name><name><surname>Batsford</surname><given-names>WP</given-names></name><name><surname>Lampert</surname><given-names>R</given-names></name></person-group>. <article-title>Benefits of cardiac rehabilitation in patients with implantable cardioverter-defibrillators: a patient survey</article-title>. <source>Arch Phys Med Rehabil</source> <year>2005</year>; <volume>86</volume>(<issue>10</issue>): <fpage>1924</fpage>–<lpage>1928</lpage>.</citation></ref>
<ref id="bibr26-1741826711414624"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O’Connor</surname><given-names>CM</given-names></name><name><surname>Whellan</surname><given-names>DJ</given-names></name><name><surname>Lee</surname><given-names>KL</given-names></name><name><surname>Keteyian</surname><given-names>SJ</given-names></name><name><surname>Cooper</surname><given-names>LS</given-names></name><name><surname>Ellis</surname><given-names>SJ</given-names></name><etal/></person-group>. <article-title>Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial</article-title>. <source>JAMA</source> <year>2009</year>; <volume>301</volume>(<issue>14</issue>): <fpage>1439</fpage>–<lpage>1450</lpage>.</citation></ref>
<ref id="bibr27-1741826711414624"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>PD</given-names></name><name><surname>Franklin</surname><given-names>BA</given-names></name><name><surname>Balady</surname><given-names>GJ</given-names></name><name><surname>Blair</surname><given-names>SN</given-names></name><name><surname>Corrado</surname><given-names>D</given-names></name><name><surname>Estes</surname><given-names>NA</given-names><suffix>3rd</suffix></name><etal/></person-group>. <article-title>Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology</article-title>. <source>Circulation</source> <year>2007</year>; <volume>115</volume>(<issue>17</issue>): <fpage>2358</fpage>–<lpage>2368</lpage>.</citation></ref>
<ref id="bibr28-1741826711414624"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wisløff</surname><given-names>U</given-names></name><name><surname>Stoylen</surname><given-names>A</given-names></name><name><surname>Loennechen</surname><given-names>JP</given-names></name><name><surname>Bruvold</surname><given-names>M</given-names></name><name><surname>Rognmo</surname><given-names>O</given-names></name><name><surname>Haram</surname><given-names>PM</given-names></name><etal/></person-group>. <article-title>Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study</article-title>. <source>Circulation</source> <year>2007</year>; <volume>115</volume>(<issue>24</issue>): <fpage>3086</fpage>–<lpage>3094</lpage>.</citation></ref>
<ref id="bibr29-1741826711414624"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noel</surname><given-names>M</given-names></name><name><surname>Jobin</surname><given-names>J</given-names></name><name><surname>Marcoux</surname><given-names>A</given-names></name><name><surname>Poirier</surname><given-names>P</given-names></name><name><surname>Dagenais</surname><given-names>GR</given-names></name><name><surname>Bogaty</surname><given-names>P</given-names></name></person-group>. <article-title>Can prolonged exercise-induced myocardial ischaemia be innocuous?</article-title>. <source>Eur Heart J</source> <year>2007</year>; <volume>28</volume>(<issue>13</issue>): <fpage>1559</fpage>–<lpage>1565</lpage>.</citation></ref>
<ref id="bibr30-1741826711414624"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>RA</given-names></name><name><surname>Bhandari</surname><given-names>AK</given-names></name><name><surname>McKay</surname><given-names>CR</given-names></name><name><surname>Au</surname><given-names>PK</given-names></name><name><surname>Rahimtoola</surname><given-names>SH</given-names></name></person-group>. <article-title>Life-threatening ventricular tachycardia and fibrillation induced by painless myocardial ischemia during exercise testing</article-title>. <source>JAMA</source> <year>1987</year>; <volume>257</volume>(<issue>14</issue>): <fpage>1937</fpage>–<lpage>1940</lpage>.</citation></ref>
<ref id="bibr31-1741826711414624"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Specchia</surname><given-names>G</given-names></name><name><surname>La Rovere</surname><given-names>MT</given-names></name><name><surname>Falcone</surname><given-names>C</given-names></name><name><surname>Campana</surname><given-names>C</given-names></name><name><surname>Traversi</surname><given-names>E</given-names></name><name><surname>Caizzi</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Cardiac arrhythmias during exercise-induced myocardial ischaemia in patients with coronary artery disease</article-title>. <source>Eur Heart J</source> <year>1986</year>; <volume>7</volume>(<issue>Suppl A</issue>): <fpage>45</fpage>–<lpage>52</lpage>.</citation></ref>
<ref id="bibr32-1741826711414624"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sears</surname><given-names>SF</given-names><suffix>Jr</suffix></name><name><surname>Todaro</surname><given-names>JF</given-names></name><name><surname>Lewis</surname><given-names>TS</given-names></name><name><surname>Sotile</surname><given-names>W</given-names></name><name><surname>Conti</surname><given-names>JB</given-names></name></person-group>. <article-title>Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review</article-title>. <source>Clin Cardiol</source> <year>1999</year>; <volume>22</volume>(<issue>7</issue>): <fpage>481</fpage>–<lpage>489</lpage>.</citation></ref>
<ref id="bibr33-1741826711414624"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van den Broek</surname><given-names>KC</given-names></name><name><surname>Pedersen</surname><given-names>SS</given-names></name><name><surname>van der Voort</surname><given-names>PH</given-names></name><name><surname>Alings</surname><given-names>M</given-names></name><name><surname>Denollet</surname><given-names>J</given-names></name></person-group>. <article-title>Depressive symptoms are associated with mortality in patients with an ICD</article-title>. <source>Abstract Cardiostim</source> <year>2010</year>; <volume>136</volume>: <fpage>59</fpage>–<lpage>59</lpage>.</citation></ref>
<ref id="bibr34-1741826711414624"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bourke</surname><given-names>JP</given-names></name><name><surname>Turkington</surname><given-names>D</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>McComb</surname><given-names>JM</given-names></name><name><surname>Tynan</surname><given-names>M</given-names></name></person-group>. <article-title>Florid psychopathology in patients receiving shocks from implanted cardioverter-defibrillators</article-title>. <source>Heart</source> <year>1997</year>; <volume>78</volume>(<issue>6</issue>): <fpage>581</fpage>–<lpage>583</lpage>.</citation></ref>
<ref id="bibr35-1741826711414624"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCready</surname><given-names>MJ</given-names></name><name><surname>Exner</surname><given-names>DV</given-names></name></person-group>. <article-title>Quality of life and psychological impact of implantable cardioverter defibrillators: focus on randomized controlled trial data</article-title>. <source>Card Electrophysiol Rev</source> <year>2003</year>; <volume>7</volume>(<issue>1</issue>): <fpage>63</fpage>–<lpage>70</lpage>.</citation></ref>
<ref id="bibr36-1741826711414624"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>DL</given-names></name><name><surname>Hamilton</surname><given-names>GA</given-names></name></person-group>. <article-title>Quality of life in implanted cardioverter defibrillator recipients: the impact of a device shock</article-title>. <source>Heart Lung</source> <year>2005</year>; <volume>34</volume>(<issue>3</issue>): <fpage>169</fpage>–<lpage>178</lpage>.</citation></ref>
<ref id="bibr37-1741826711414624"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bostwick</surname><given-names>JM</given-names></name><name><surname>Sola</surname><given-names>CL</given-names></name></person-group>. <article-title>An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life</article-title>. <source>Psychiatr Clin North Am</source> <year>2007</year>; <volume>30</volume>(<issue>4</issue>): <fpage>677</fpage>–<lpage>688</lpage>.</citation></ref>
<ref id="bibr38-1741826711414624"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>SS</given-names></name><name><surname>van Domburg</surname><given-names>RT</given-names></name><name><surname>Theuns</surname><given-names>DA</given-names></name><name><surname>Jordaens</surname><given-names>L</given-names></name><name><surname>Erdman</surname><given-names>RA</given-names></name></person-group>. <article-title>Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners</article-title>. <source>Psychosom Med</source> <year>2004</year>; <volume>66</volume>(<issue>5</issue>): <fpage>714</fpage>–<lpage>719</lpage>.</citation></ref>
<ref id="bibr39-1741826711414624"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spindler</surname><given-names>H</given-names></name><name><surname>Johansen</surname><given-names>JB</given-names></name><name><surname>Andersen</surname><given-names>K</given-names></name><name><surname>Mortensen</surname><given-names>P</given-names></name><name><surname>Pedersen</surname><given-names>SS</given-names></name></person-group>. <article-title>Gender differences in anxiety and concerns about the cardioverter defibrillator</article-title>. <source>Pacing Clin Electrophysiol</source> <year>2009</year>; <volume>32</volume>(<issue>5</issue>): <fpage>614</fpage>–<lpage>621</lpage>.</citation></ref>
<ref id="bibr40-1741826711414624"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morken</surname><given-names>IM</given-names></name><name><surname>Severinsson</surname><given-names>E</given-names></name><name><surname>Karlsen</surname><given-names>B</given-names></name></person-group>. <article-title>Reconstructing unpredictability: experiences of living with an implantable cardioverter defibrillator over time</article-title>. <source>J Clin Nurs</source> <year>2010</year>; <volume>19</volume>(<issue>3–4</issue>): <fpage>537</fpage>–<lpage>546</lpage>.</citation></ref>
<ref id="bibr41-1741826711414624"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wojcicka</surname><given-names>M</given-names></name><name><surname>Lewandowski</surname><given-names>M</given-names></name><name><surname>Smolis-Bak</surname><given-names>E</given-names></name><name><surname>Szwed</surname><given-names>H</given-names></name></person-group>. <article-title>Psychological and clinical problems in young adults with implantable cardioverter-defibrillators</article-title>. <source>Kardiol Pol</source> <year>2008</year>; <volume>66</volume>(<issue>10</issue>): <fpage>1050</fpage>–<lpage>1058</lpage>. <comment>discussion 9⊟60</comment>.</citation></ref>
</ref-list>
</back>
</article>